DBCO-P-LPK
DBCO-P-LPK is a DBCO-modified colorectal cancer-specific binding peptide that serves as a key intermediate for targeted anticancer conjugates. DBCO-P-LPK enables the synthesis of the P-LPK-Camptothecin (HY-16560) conjugate. DBCO-P-LPK is applicable to the research of colorectal cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C73H107N15O22S
- Masse moléculaire:1578.78
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Chemical Information
-
Masse moléculaire 1578.78
-
Formule C73H107N15O22S
-
Sequence
{DBCO}-Leu-Pro-Lys-Thr-Val-Ser-Ser-Asp-Met-Ser-Leu-Asn
-
Sequence Shortening
{DBCO}-LPKTVSSDMSLN
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)